Back
Back

iShares Healthcare Innovation

Global healthcare companies

(DRDR)
£6.32
Previous business day’s close price
‑£1.18 (‑15.71%)
max available period
£5
£8.14
04 Jan 21
14 Jan 25

Details

ETF description

The iShares Healthcare Innovation ETF is designed to provide investors with exposure to companies that are at the forefront of technological advancements and innovation within the healthcare sector. By tracking the NYSE FactSet Global Healthcare Innovators index, this ETF focuses on firms involved in pioneering medical technologies, biotechnology, pharmaceuticals, and healthcare services, aiming to capture the growth potential from the latest advancements in healthcare.

Issuer details

iShares ETFs are issued and managed by BlackRock, the world’s largest asset management company.

With 800+ products globally and over $2trn in assets (as at June 2024), iShares ETFs are a flexible, low‑cost way for investors to gain exposure to various market segments, including fixed income, emerging markets and broad‑based indexes.

Index details

The Healthcare Innovation index offers specialized exposure to companies that are leading the way in healthcare advancements and breakthroughs. By focusing on innovative technologies, treatments, and solutions, the index aims to deliver growth potential and investment opportunities driven by the latest trends in healthcare. It serves as a valuable tool for investors seeking to capitalize on the transformative impact of healthcare innovation while benefiting from diversified exposure to cutting‑edge developments in the sector.

This ETF is in collections:

Thematics
Healthcare

Key information

Key investor information

ETF Breakdown

Region
Sector
argenx SE
2.6%
Gilead Sciences, Inc.
2.2%
UCB SA
2.2%
Natera Inc
2.2%
Insulet Corporation
2.1%
Bristol‑Myers Squibb Co.
2.0%
Intuitive Surgical Inc
1.9%
Illumina Inc
1.8%
Boston Scientific Corp.
1.8%
Lonza Group AG
1.7%
Abbott Laboratories
1.7%
Abbvie Inc
1.6%
Neurocrine Biosciences, Inc.
1.6%
Samsung Biologics Co Ltd
1.6%
Agilent Technologies Inc.
1.6%
Hologic, Inc.
1.5%
Johnson & Johnson
1.5%
Sarepta Therapeutics Inc
1.5%
Medtronic Plc
1.5%
Celltrion Inc
1.5%
Pfizer Inc.
1.5%
Bio‑Techne Corp
1.4%
Novartis AG
1.4%
IQVIA
1.4%
Thermo Fisher
1.4%
Danaher Corp.
1.4%
Exact Sciences Corp.
1.4%
Exelixis Inc
1.4%
AMGEN Inc.
1.3%
Qiagen N.V.
1.3%
Edwards Lifesciences Corp
1.3%
Sysmex Corporation
1.3%
BeiGene Ltd
1.3%
Charles River Laboratories International Inc.
1.3%
GSK Plc
1.3%
Genmab
1.2%
Merck & Co Inc
1.2%
Pro Medicus
1.1%
Shimadzu Corporation
1.1%
Biogen Inc
1.1%
Dexcom Inc
1.0%
Intra‑Cellular Therapies Inc
1.0%
Medpace Holdings Inc
1.0%
Eisai Co Ltd
1.0%
Repligen Corp.
1.0%
Bio‑Rad Laboratories Inc.
1.0%
Revolution Medicines Inc
1.0%
Halozyme Therapeutics Inc.
0.8%
Lantheus Holdings Inc
0.8%
Sartorius AG
0.8%
Zealand Pharma A/S.
0.8%
Biomerieux
0.7%
Ionis Pharmaceuticals Inc
0.7%
Alkermes plc
0.6%
Maximus Inc.
0.6%
Ipsen
0.6%
Siegfried Holding AG
0.6%
TG Therapeutics Inc
0.6%
Asahi Intecc Co. Ltd.
0.5%
BridgeBio Pharma Inc
0.5%
Guardant Health Inc
0.5%
Sectra Class B
0.5%
PTC Therapeutics Inc
0.5%
Akeso Inc
0.4%
Corvel Corp.
0.4%
Moderna Inc
0.4%
Axsome Therapeutics Inc
0.4%
Rhythm Pharmaceuticals Inc.
0.4%
NovoCure Ltd
0.4%
Tecan Group AG
0.4%
Veracyte Inc
0.4%
Diasorin S.p.A.
0.4%
Neogen Corp.
0.3%
Arcellx Inc
0.3%
Denali Therapeutics Inc
0.3%
Twist Bioscience Corp
0.3%
Catalyst Pharmaceuticals Inc
0.3%
LivaNova PLC
0.3%
Tandem Diabetes Care Inc
0.3%
Acadia Pharmaceuticals Inc
0.3%
QuidelOrtho Corporation
0.3%
Merus N.V
0.3%
Bavarian Nordic A/S
0.3%
SK Biopharmaceuticals Co. Ltd.
0.3%
Bachem Holding AG
0.3%
Elekta AB (publ)
0.3%
Supernus Pharmaceuticals Inc
0.3%
Geron Corp.
0.3%
Ideaya Biosciences Inc
0.3%
JEOL Ltd.
0.3%
Ligand Pharmaceuticals, Inc.
0.3%
Nurix Therapeutics Inc
0.3%
Sawai Group Holdings Co Ltd
0.2%
Beam Therapeutics Inc
0.2%
Dynavax Technologies Corp.
0.2%
Fortrea Holdings Inc
0.2%
Lion Biotechnologies Inc
0.2%
United Laboratories International Holdings Ltd.
0.2%
HUTCHMED (China) Limited
0.2%
Integra Lifesciences Holdings Corp
0.2%
10x Genomics Inc
0.2%
Biocryst Pharmaceuticals Inc.
0.2%
H. Lundbeck AS
0.2%
Atricure Inc
0.2%
Peptron Inc.
0.2%
Xencor Inc
0.2%
Arvinas Operations Inc
0.2%
Evotec SE
0.2%
Harmony Biosciences Holdings Inc
0.2%
ANI Pharmaceuticals Inc
0.2%
Apollo Medical Holdings Inc
0.2%
Certara Inc
0.2%
Chemometec AS
0.2%
Evolent Health Inc
0.2%
Myriad Genetics, Inc.
0.2%
Pharmamar S.A.
0.1%
Recursion Pharmaceuticals Inc
0.1%
Schrodinger Inc
0.1%
Xvivo Perfusion AB
0.1%
Caredx Inc
0.1%
Galapagos NV
0.1%
Lunit Inc
0.1%
Oxford Nanopore Technologies Plc
0.1%
Neuren Pharmaceuticals Ltd
0.1%
Cytek BioSciences Inc
0.1%
Novavax, Inc.
0.1%
Zymeworks Inc
0.1%
Adaptive Biotechnologies Corp
0.1%
Avid Bioservices Inc
0.1%
SK bioscience Co. Ltd.
0.1%
uniQure N.V.
0.1%
BioArctic AB
0.1%
Castle Biosciences Inc
0.1%
Prothena Corporation plc
0.1%
Seegene Inc
0.1%
Vir Biotechnology Inc
0.1%
ABL Bio Inc.
< 0.1%
AbCellera Biologics Inc
< 0.1%
Axogen Inc.
< 0.1%
Keymed Biosciences Inc.
< 0.1%
Arcus Biosciences Inc
< 0.1%
CompuGroup Medical SE & Co. KgaA
< 0.1%
Maravai LifeSciences Holdings Inc
< 0.1%
Pharming Group N.V.
< 0.1%
ST Pharm Co Ltd
< 0.1%
Tobii Dynavox AB
< 0.1%
Japan Lifeline Co Ltd
< 0.1%
Pacific Biosciences of California Inc
< 0.1%
Polaris Group
< 0.1%
Relay Therapeutics Inc
< 0.1%
Eiken Chemical Co Ltd
< 0.1%
ImmunityBio Inc
< 0.1%
Roche Holding AG
< 0.1%
Simulations Plus Inc.
< 0.1%
Arcturus Therapeutics Holdings Inc
< 0.1%
Quanterix Corp
< 0.1%
SD Biosensor Inc.
< 0.1%
Allogene Therapeutics Inc
< 0.1%
ITeos Therapeutics Inc
< 0.1%
Orasure Technologies Inc.
< 0.1%
Regenxbio Inc
< 0.1%
RemeGen Co. Ltd.
< 0.1%
Sage Therapeutics Inc
< 0.1%
Shinpoong Pharmaceutical
< 0.1%
Stoke Therapeutics Inc
< 0.1%
Takara Bio Inc.
< 0.1%
Vanda Pharmaceuticals Inc
< 0.1%
Y‑Mabs Therapeutics Inc
< 0.1%
4D Molecular Therapeutics Inc
< 0.1%
ATAI Life Sciences N.V.
< 0.1%
Accolade Inc
< 0.1%
AnaptysBio Inc
< 0.1%
Macrogenics Inc
< 0.1%
Shanghai Junshi Biosciences Co Ltd
< 0.1%
Sillajen Biotherapeutics Inc
< 0.1%
UroGen Pharma Ltd
< 0.1%
Valneva SE
< 0.1%
Venus Medtech (Hangzhou) Inc.
< 0.1%
Alector Inc
< 0.1%
Cellivery Therapeutics Inc.
< 0.1%
Fate Therapeutics Inc
< 0.1%
I‑Sens USA Inc
< 0.1%
Idorsia Ltd
< 0.1%
Lyell Immunopharma Inc
< 0.1%
Mersana Therapeutics Inc
< 0.1%
Nevro Corp
< 0.1%
PHC Holdings Corporation
< 0.1%
Agenus Inc
< 0.1%
Caribou Biosciences Inc
< 0.1%
Nkmax Co. Ltd
< 0.1%
Sutro Biopharma Inc
< 0.1%
Others
0.2%
£6.32
Previous business day’s close price

Capital at risk

Why InvestEngine

Unbeatable value

From commission‑free investing, to zero‑ISA fees, we’re proud of our low fees.
Here's how we're able to do it

Choice of 760+ ETFs

Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
Browse investments

Actionable insights

Know exactly which companies, sectors and regions are in your portfolio.

Powerful automation

Grow your wealth the easy way with automated investing features

Easy diversification

Fractional investing lets you put as little as £1 in any ETF.

DIY or Managed

Build and manage your own portfolio or leave it to us.

ETFs have spreads and annual charges and come with risks like market volatility, liquidity, and concentration, and may not always accurately track their index. Past performance and forecasts are not reliable indicators of future results. The value of your investments, including any income, can rise or fall. You may get back less than you originally invested.
Our support is available Monday-Friday 5:30am to 9:00pm
and Saturday-Sunday 8:30am to 5:30pm
Why InvestEngine
Accounts
Compare
Portfolios
Calculators
Legal information
Our Address
InvestEngine (UK) Limited, 4th Floor, 57 Great Suffolk Street, London, SE1 0BB
Why InvestEngine
Accounts
Portfolios
Calculators
Compare
Legal information
Our Address
InvestEngine (UK) Limited, 4th Floor, 57 Great Suffolk Street, London, SE1 0BB
Facebook
Twitter
Linkedin
Instagram
Community
Visit our blog at blog.investengine.com
Whenever you invest, your capital is at risk
This could mean the value of your investments goes down as well as up.
Understand more about investment risk.
© InvestEngine Limited 2025. All rights reserved.

Capital at risk